肾损伤分子1与急性肾损伤的研究进展

被引：1

作者：

娄菲菲 ^{[1
]}

吕哲 ^{[2
]}

王月华 ^{[1
]}

机构：

[1] 河北医科大学第三医院肾内科

[2] 河北省中医院肾内科

来源：

临床荟萃 | 2016年 / 31卷 / 07期

关键词：

肾疾病; 肾小管,近端;

D O I：

暂无

中图分类号：

R692 [肾疾病];

学科分类号：

摘要：

急性肾损伤(acute kidney injury,AKI)是临床常见病,许多患者进展为终末期肾脏病需要行肾脏替代治疗,并且医院获得性的AKI发生率正在增加。患有AKI的人群进展为慢性肾脏病和终末期肾脏病的风险更高。肾小管上皮细胞在急性损伤后具有修复功能,肾损伤分子1在此过程中发挥重要作用。

引用

页码：793 / 796

页数：4

共 32 条

[1] 肾损伤分子1在药物相关性急性肾损伤早期诊断中的意义
廖纯兴
潘巧玲
杨建泉
杨碧君
黄贵阳
何楠
张军
[J]. 热带医学杂志, 2012, 12 (07) : 854 - 856
[2] 肾损伤分子-1在肾脏损伤中作用研究进展
徐良贤
郑美蓉
何玉茂
[J]. 南昌大学学报(医学版), 2012, 52 (09) : 89 - 92+97
[3] Urinary Biomarkers in the Clinical Prognosis and Early Detection of Acute Kidney Injury. Jay L. Koyner,Vishal S. Vaidya,Michael R. Bennett. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY . 2010
[4] One-year mortality among Danish intensive care patients with acute kidney injury: a cohort study. Henrik Gammelager,Christian Fynbo Christiansen,Martin Berg Johansen. Journal of Critical Care . 2012
[5] Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Zhou Yuzhao,Vaidya Vishal S,Brown Ronald P,Zhang Jun,Rosenzweig Barry A,Thompson Karol L,Miller Terry J,Bonventre Joseph V,Goering Peter L. Toxicological sciences : an official journal of the Society of Toxicology . 2007
[6] Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Han WK,Wagener G,Zhu Y, et al. Clin J Am Soc Nephrol . 2009
[7] Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. Liangos Orfeas,Perianayagam Mary C,Vaidya Vishal S,Han Won K,Wald Ron,Tighiouart Hocine,MacKinnon Robert W,Li Lijun,Balakrishnan Vaidyanathapuram S,Pereira Brian J G,Bonventre Joseph V,Jaber Bertrand L. Journal of the American Society of Nephrology : JASN . 2007
[8] Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Ichimura T,Hung CC,Yang SA,et al. American Journal of Physiology-Renal Physiology . 2004
[9] Out of hospital outcome and quality of life in survivors of combined acute multiple organ and renal failure treated with continuous venovenous hemofiltration/hemodiafiltration
Gopal, I
Bhonagiri, S
Ronco, C
Bellomo, R
[J]. INTENSIVE CARE MEDICINE, 1997, 23 (07) : 766 - 772
[10] Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care[J] . Maarit Korkeila,Esko Ruokonen,Jukka Takala. &nbspIntensive Care Medicine . 2000 (12)

← 1 2 3 4 →